Ruth Exner

4PUBLICATIONS
14CO-AUTHORS
Predictive and prognostic markersNeurology and neuromuscular diseasesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 05, 2025
HER2/CEP17 ratio predicts residual cancer burden after neoadjuvant dual HER2 blockade: real-world data in patients with primary HER2-amplified breast cancer.

Myriam Stolz, Alex Farr, Kristina A Tendl-Schulz

|Mar 02, 2025
Prognostic relevance of the neurological symptom burden in brain metastases from breast cancer.

Ariane Steindl, Clara Zach, Luzia Berchtold

|Mar 25, 2021
Conventional versus reverse sequence of neoadjuvant epirubicin/cyclophosphamide and docetaxel: sequencing results from ABCSG-34.

Rupert Bartsch, Christian F Singer, Georg Pfeiler

|Oct 10, 2017
Local therapies for breast cancer.

Ruth Exner

Pageof 1

Frequent Collaborators

3 joint publications

Christian F Singer

2 joint publications

Zsuzsanna Bago-Horvath

1 joint publications

Marija Balic

1 joint publications

Ariane Steindl